Cargando…
Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461138/ https://www.ncbi.nlm.nih.gov/pubmed/34559403 http://dx.doi.org/10.1007/s13300-021-01154-3 |
| _version_ | 1784571915932794880 |
|---|---|
| author | Emral, Rifat Haymana, Cem Demirci, Ibrahim Tasci, Ilker Sahin, Mustafa Cakal, Erman Ata, Naim Unluturk, Ugur Demir, Tevfik Ertugrul, Derun Sahin, Ibrahim Atmaca, Aysegül Celik, Osman Caglayan, Murat Arga, Kazim Yalcin Dagdelen, Selcuk Salman, Serpil Satman, Ilhan Sonmez, Alper |
| author_facet | Emral, Rifat Haymana, Cem Demirci, Ibrahim Tasci, Ilker Sahin, Mustafa Cakal, Erman Ata, Naim Unluturk, Ugur Demir, Tevfik Ertugrul, Derun Sahin, Ibrahim Atmaca, Aysegül Celik, Osman Caglayan, Murat Arga, Kazim Yalcin Dagdelen, Selcuk Salman, Serpil Satman, Ilhan Sonmez, Alper |
| author_sort | Emral, Rifat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8461138 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84611382021-09-24 Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study Emral, Rifat Haymana, Cem Demirci, Ibrahim Tasci, Ilker Sahin, Mustafa Cakal, Erman Ata, Naim Unluturk, Ugur Demir, Tevfik Ertugrul, Derun Sahin, Ibrahim Atmaca, Aysegül Celik, Osman Caglayan, Murat Arga, Kazim Yalcin Dagdelen, Selcuk Salman, Serpil Satman, Ilhan Sonmez, Alper Diabetes Ther Correction Springer Healthcare 2021-09-24 2021-11 /pmc/articles/PMC8461138/ /pubmed/34559403 http://dx.doi.org/10.1007/s13300-021-01154-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Emral, Rifat Haymana, Cem Demirci, Ibrahim Tasci, Ilker Sahin, Mustafa Cakal, Erman Ata, Naim Unluturk, Ugur Demir, Tevfik Ertugrul, Derun Sahin, Ibrahim Atmaca, Aysegül Celik, Osman Caglayan, Murat Arga, Kazim Yalcin Dagdelen, Selcuk Salman, Serpil Satman, Ilhan Sonmez, Alper Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
| title | Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
| title_full | Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
| title_fullStr | Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
| title_full_unstemmed | Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
| title_short | Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
| title_sort | correction to: lower covid-19 mortality in patients with type 2 diabetes mellitus taking dipeptidyl peptidase-4 inhibitors: results from a turkish nationwide study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461138/ https://www.ncbi.nlm.nih.gov/pubmed/34559403 http://dx.doi.org/10.1007/s13300-021-01154-3 |
| work_keys_str_mv | AT emralrifat correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT haymanacem correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT demirciibrahim correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT tasciilker correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT sahinmustafa correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT cakalerman correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT atanaim correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT unluturkugur correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT demirtevfik correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT ertugrulderun correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT sahinibrahim correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT atmacaaysegul correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT celikosman correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT caglayanmurat correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT argakazimyalcin correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT dagdelenselcuk correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT salmanserpil correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT satmanilhan correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy AT sonmezalper correctiontolowercovid19mortalityinpatientswithtype2diabetesmellitustakingdipeptidylpeptidase4inhibitorsresultsfromaturkishnationwidestudy |